Patient With Relapsed Large Cell Lymphoma: Reference Product or Biosimilar?

In this webinar, Drs. Andrew Zelenetz and Gary Lyman review clinical trial data and discuss extrapolation as it relates to the potential use of a biosimilar in a patient with relapsed large cell lymphoma.